Remote patient monitoring for diabetes and related chronic conditions blog | Glooko

Passer de diasend^® à Glooko^® ? Cliquez ici pour savoir comment mettre à niveau votre solution.

Declining diabetes outcomes after patient disengagement from Glooko®
Supporting remote patient monitoring (RPM) by leveraging machine learning to predict dropout risk
How to scale telehealth programs by leveraging diabetes data to identify “at-risk” patients

Living with diabetes during the COVID-19 pandemic: A real-world look at how people with diabetes have been impacted

People with diabetes face a greater chance of experiencing serious complications caused by the coronavirus. To understand the impact of COVID-19 on people with diabetes, we analyzed glucose, insulin, and activity trends from users of Glooko solutions in the United States.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

National Blood Donor Month

According to a quick search, the human body contains 120,000 (!!) drops of blood. Depending on your type of diabetes and your individual treatment plan, your doctor may recommend anywhere from 2-10 blood glucose (BG) checks per day. We know that everyone is different and the number of BG checks will vary person to person.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

My Journey to Glooko and the World of Diabetes Management

In search of my path, I joined the Peace Corps and was sent to a rural town in Ecuador, South America, to work in youth and family development. There, living in isolation and with limited resources, I learned “how to learn” so that I could accomplish my personal goals and the goals of my community. This involved a lot of trial and error, research, and YouTube videos (I now consider myself a proficient balloon animal artist!).Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Meet Sondra! Learn How She Shares Data with Her Doctor

I was diagnosed at age 57 originally with Type 2 diabetes. Before my diagnosis, I was experiencing massive cravings for soda, fuzzy vision and weight loss. When I went in to see my doctor, my blood glucose level was 568 mg/dL. I was immediately started on Metformin.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Meet Steven! Learn How He Tracks His Carb Intake

My body was not metabolizing what I was eating because my pancreas wasn’t working. As a result I had a Whipple procedure on January 3, 2006. At this time, I was still not a diabetic. On July 7, 2008, I retired from my job as an Educational Administrator for the New York City Department of Education.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Nutrition Recommendations from a Registered Dietitian

Nutrition is extremely important for everyone, especially if you have diabetes. Some of us look at the nutrition facts on food labels and count calories, fat, carbohydrates, sugars, and protein.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Individual Differences in Fasting Blood Glucose (FBG)

A fasting blood glucose (FBG) reading between 70-100 mg/dL is typically regarded as normal in people without diabetes¹. While this range serves as a standard reference for assessing one’s glycemic status, inter-individual differences exist across the population. A better understanding of one’s own FBG range might provide a more actionable basis for reference.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Impacting Diabetes in Asia, One Person At A Time

She is a mom of two kids ages 12 and 8 and a loving wife. She is an HR Specialist who works 4 days a week, a special arrangement with a supportive boss. She watches her diet and plans to get an activity tracker soon. Her motto is Take care of your diabetes, so you are able to take care of everything else.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Join Glooko’s 2021 Wellness Challenge

To further our commitment to our community of patients with diabetes, clinical researchers and healthcare providers, Glooko is holding a Wellness Challenge for Team Glooko October 4 to 10, 2021, and we want you to get involved.Continue Reading »

October 8, 2021 || WRITTEN BY Glooko

Les produits ne sont pas tous disponibles dans tous les pays. Veuillez contacter votre représentant local Glooko pour plus d’informations.

Toutes les marques déposées de tiers et les noms et logos de produits et d’entreprises tiers affichés sur le site Web et utilisés dans les différents supports restent la propriété de leurs détenteurs respectifs. Sauf indication contraire expresse, l’utilisation par Glooko de noms, de logos ou de marques de tiers n’indique pas une relation, un parrainage ou une approbation entre Glooko et leurs propriétaires respectifs.

Glooko® est un dispositif médical de Classe I marqué CE. Glooko® est une application destinée à la gestion des données relatives au diabète pour les personnes atteintes de diabète et leur équipe soignante, permettant une Télésurveillance, si cela est nécessaire. Fabricant : Glooko, Inc., société située 411 High Street, Palo Alto, Californie, 94301 (États-Unis)